GB829246A - Improvements in or relating to new perfluoroalkyl-phenothiazine derivatives - Google Patents
Improvements in or relating to new perfluoroalkyl-phenothiazine derivativesInfo
- Publication number
- GB829246A GB829246A GB32856/57A GB3285657A GB829246A GB 829246 A GB829246 A GB 829246A GB 32856/57 A GB32856/57 A GB 32856/57A GB 3285657 A GB3285657 A GB 3285657A GB 829246 A GB829246 A GB 829246A
- Authority
- GB
- United Kingdom
- Prior art keywords
- carbon atoms
- alkyl
- trifluoromethylphenthiazine
- piperazine
- propyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 229940066767 systemic antihistamines phenothiazine derivative Drugs 0.000 title 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 18
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 abstract 9
- -1 ethyl radicals Chemical class 0.000 abstract 7
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 abstract 6
- 125000000217 alkyl group Chemical group 0.000 abstract 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract 4
- 238000006243 chemical reaction Methods 0.000 abstract 3
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 abstract 2
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 2
- TZIHFWKZFHZASV-UHFFFAOYSA-N methyl formate Chemical compound COC=O TZIHFWKZFHZASV-UHFFFAOYSA-N 0.000 abstract 2
- 125000002950 monocyclic group Chemical group 0.000 abstract 2
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 abstract 2
- OZYMPEDHLCZKFH-UHFFFAOYSA-N 1,1,2,2,3,3,3-heptafluoropropylbenzene Chemical compound FC(F)(F)C(F)(F)C(F)(F)C1=CC=CC=C1 OZYMPEDHLCZKFH-UHFFFAOYSA-N 0.000 abstract 1
- CDLGQYBFSVFACY-UHFFFAOYSA-N 1-(1,1,2,2,3,3,3-heptafluoropropyl)-3-nitrobenzene Chemical compound FC(C(C1=CC(=CC=C1)[N+](=O)[O-])(F)F)(C(F)(F)F)F CDLGQYBFSVFACY-UHFFFAOYSA-N 0.000 abstract 1
- ZKDOQFPDSUOLGF-UHFFFAOYSA-N 1-bromo-3-chloro-2-methylpropane Chemical compound ClCC(C)CBr ZKDOQFPDSUOLGF-UHFFFAOYSA-N 0.000 abstract 1
- ZRWNMUKRJDYRFO-UHFFFAOYSA-N 2-[3-(1,1,2,2,3,3,3-heptafluoropropyl)anilino]benzoic acid Chemical compound FC(C(C=1C=C(C=CC1)NC1=C(C(=O)O)C=CC=C1)(F)F)(C(F)(F)F)F ZRWNMUKRJDYRFO-UHFFFAOYSA-N 0.000 abstract 1
- IKCLCGXPQILATA-UHFFFAOYSA-N 2-chlorobenzoic acid Chemical compound OC(=O)C1=CC=CC=C1Cl IKCLCGXPQILATA-UHFFFAOYSA-N 0.000 abstract 1
- SVDDJQGVOFZBNX-UHFFFAOYSA-N 2-chloroethyl carbonochloridate Chemical compound ClCCOC(Cl)=O SVDDJQGVOFZBNX-UHFFFAOYSA-N 0.000 abstract 1
- USOGGTQARFXNEM-UHFFFAOYSA-N 3-(1,1,2,2,3,3,3-heptafluoropropyl)aniline Chemical compound NC1=CC=CC(C(F)(F)C(F)(F)C(F)(F)F)=C1 USOGGTQARFXNEM-UHFFFAOYSA-N 0.000 abstract 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 abstract 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 abstract 1
- VGCXGMAHQTYDJK-UHFFFAOYSA-N Chloroacetyl chloride Chemical compound ClCC(Cl)=O VGCXGMAHQTYDJK-UHFFFAOYSA-N 0.000 abstract 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 abstract 1
- 239000007868 Raney catalyst Substances 0.000 abstract 1
- NPXOKRUENSOPAO-UHFFFAOYSA-N Raney nickel Chemical compound [Al].[Ni] NPXOKRUENSOPAO-UHFFFAOYSA-N 0.000 abstract 1
- 229910000564 Raney nickel Inorganic materials 0.000 abstract 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 abstract 1
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 abstract 1
- 239000005864 Sulphur Substances 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 125000002252 acyl group Chemical group 0.000 abstract 1
- 125000004423 acyloxy group Chemical group 0.000 abstract 1
- 125000001931 aliphatic group Chemical group 0.000 abstract 1
- 125000003342 alkenyl group Chemical group 0.000 abstract 1
- 125000002947 alkylene group Chemical group 0.000 abstract 1
- BCUFIZDAINPDHF-UHFFFAOYSA-N benzyl 2,5-diethylpiperazine-1-carboxylate Chemical compound CCC1CNC(CC)CN1C(=O)OCC1=CC=CC=C1 BCUFIZDAINPDHF-UHFFFAOYSA-N 0.000 abstract 1
- 125000000490 cinnamyl group Chemical group C(C=CC1=CC=CC=C1)* 0.000 abstract 1
- 125000001316 cycloalkyl alkyl group Chemical group 0.000 abstract 1
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 1
- 238000006114 decarboxylation reaction Methods 0.000 abstract 1
- 125000005117 dialkylcarbamoyl group Chemical group 0.000 abstract 1
- FBCCMZVIWNDFMO-UHFFFAOYSA-N dichloroacetyl chloride Chemical compound ClC(Cl)C(Cl)=O FBCCMZVIWNDFMO-UHFFFAOYSA-N 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- LNOQURRKNJKKBU-UHFFFAOYSA-N ethyl piperazine-1-carboxylate Chemical compound CCOC(=O)N1CCNCC1 LNOQURRKNJKKBU-UHFFFAOYSA-N 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 229910052740 iodine Inorganic materials 0.000 abstract 1
- 239000011630 iodine Substances 0.000 abstract 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- IWJSZNIFIDAYDY-UHFFFAOYSA-N n,n-diethylpiperazine-1-carboxamide Chemical compound CCN(CC)C(=O)N1CCNCC1 IWJSZNIFIDAYDY-UHFFFAOYSA-N 0.000 abstract 1
- 229910017604 nitric acid Inorganic materials 0.000 abstract 1
- 125000004433 nitrogen atom Chemical group N* 0.000 abstract 1
- 231100000252 nontoxic Toxicity 0.000 abstract 1
- 230000003000 nontoxic effect Effects 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 125000004193 piperazinyl group Chemical group 0.000 abstract 1
- 150000003254 radicals Chemical class 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000001117 sulphuric acid Substances 0.000 abstract 1
- 235000011149 sulphuric acid Nutrition 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
- C07D279/10—1,4-Thiazines; Hydrogenated 1,4-thiazines
- C07D279/14—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems
- C07D279/18—[b, e]-condensed with two six-membered rings
- C07D279/22—[b, e]-condensed with two six-membered rings with carbon atoms directly attached to the ring nitrogen atom
- C07D279/24—[b, e]-condensed with two six-membered rings with carbon atoms directly attached to the ring nitrogen atom with hydrocarbon radicals, substituted by amino radicals, attached to the ring nitrogen atom
- C07D279/28—[b, e]-condensed with two six-membered rings with carbon atoms directly attached to the ring nitrogen atom with hydrocarbon radicals, substituted by amino radicals, attached to the ring nitrogen atom with other substituents attached to the ring system
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention comprises compounds of the general formula <FORM:0829246/IV (b)/1> and their non-toxic acid addition salts (wherein Y is a perfluoralkyl radical of 1 to 3 carbon atoms, A is an alkylene chain of from 2 to 6 carbon atoms separating the nitrogen atoms linked thereto by at least two carbon atoms, R1 is a hydrogen atom, R2, R3, R4 and R5 are hydrogen atoms or methyl or ethyl radicals, R6 is cycloalkyl with 5 or 6 carbon atoms, cycloalkylalkyl with 6 to 10 carbon atoms, alkenyl with 2 to 6 carbon atoms, dialkylamino-lower-alkyl with 1 to 6 carbon atoms in each of the alkyl portions and 2 to 6 carbon atoms in the lower-alkyl portion, hydroxy-lower-alkyl with 2 to 6 carbon atoms in the lower alkyl portion, hydroxy-lower-alkyl-oxy-lower-alkyl, the lower-alkyl portions having 2 to 6 carbon atoms, phenyl, cinnamyl, furoyloxybutyl, furoyl, thenyl, monocyclic aralkyl with 2 to 6 carbon atoms in the alkyl portion, aliphatic acyl with 1 to 6 carbon atoms, alicyclic aliphatic acyl with 7 to 10 carbon atoms, monocyclic aryl-aliphatic acyl with 6 to 10 carbon atoms, carbomethoxy, carbethoxy, carbobenzoxy, carbamyl, dialkyl carbamyl with 1 to 6 carbon atoms in the alkyl portions, N-phenyl carbamyl, aliphatic acyloxy-lower-alkyl with 1 to 6 carbon atoms in the acyloxy portion and 2 to 6 carbon atoms in the lower-alkyl portion, or monocyclic aroyloxy-lower-alkyl with 2 to 6 carbon atoms in the lower-alkyl portion). The compounds of the invention may be made by the following general reactions: (1) condense a 2-perfluoroalkyl phenthiazine with a reactive piperazinyl ester having the desired piperazinyl alkyl group; (2) react a piperazine with a 2-perfluoroalkylphenthiazine which is substituted in the 10-position by an alkyl chain with a reactive terminal group; (3) hydrolyse off R6 (when this is an easily-removable group like acyl) in the 2-perfluorophenthiazine derivative, and react the product so obtained with a reactive ester or ethylene oxide; (4) condense a 10-(o -amino-alkyl)-2-perfluoroalkylphenthiazine with a substituted bis-(b -haloalkyl)-amine. The general reactions (1) to (3) are illustrated in the examples. 1 - Formyl - 4 - (31 - chloropropyl) - piperazine is made by reacting thionyl chloride with 1-formyl-4-(31-hydroxypropyl)-piperazine, which is made from 1-(31-hydroxypropyl)-piperazine and methyl formate. 10 - (31 - Piperazinylpropyl) - 2 - trifluoromethylphenthiazine is made by treating 10-[31-(N - formylpiperazinyl) - propyl] - 2 - trifluoromethylphenthiazine in ethanol with sodium hydroxide. 2 - Trifluoromethylphenthiazine is reacted with ethylene oxide, and the b -hydroxyethyl compound obtained is reacted with thonyl chloride to give 10-(21-chloroethyl)-2-trifluomethylphenthiazine, treatment of which with piperazine yields 10-(2-piperazinylethyl)-2-trifluoromethylphenthiazine. N - carbethoxy - N1 - (g - chloro - b - methylpropyl)-piperazine is made from N-carbethoxypiperazine and 3-bromo-2-methylpropylchloride. 10 - [3 - (N - carbethoxy - piperazinyl) - 21 - methylpropyl] - 2 - trifluoromethylphenthiazine in ethanol is treated with sodium hydroxide to give 10 - (21 - methyl - 31 - piperazinylpropyl) - 2 - trifluoromethylphenthiazine. N - diethylcarbamyl - N1 - (g - chloropropyl) - piperazine is made from N-diethylcarbamylpiperazine and g -chloropropyl bromide. N - carbobenzoxy - 2,5 - diethylpiperazine is reacted with g -chloropropyl bromide to give 4 - carbobenzoxy - 1 - (o - chloropropyl) - 2,5 - diethylpiperazine, reaction of which with 2-trifluoromethyl-phenthiazine yields 10-[31-(N-carbobenzoxy - 211,511 - diethylpiperazinyl) - propyl] - 2-trifluorophenthiazine, treatment of which with sodium hydroxide gives 10-[31-(211,511-diethylpiperazinyl) - propyl] - 2 - trifluoromethylphenthiazine. 10 - [31 - (N - hydroxyethylpiperazinyl - propyl] - 2 - trifluoromethylphenthiazine is reacted with dichloroacetyl chloride, chloroacetyl chloride and chloroethyl chloroformate to give respectively 10 - [31 - (N - dichloroacetoxyethylpiperazinyl) - propyl] - 3 - trifluoromethylphenthiazine dihydrochloride, 10-[31-(N-chloroacetoxyethylpiperazinyl) - propyl] - 2 - trifluoromethylphenthiazine dihydrochloride and 10 - [31 - (N - chloroethoxycarbonyloxyethylpiperazinyl)-propyl]-2 - trifluoromethylphenthiazine dihydrochloride. Heptafluoropropylbenzene is nitrated by a mixture of nitric acid and concentrated sulphuric acid to give 1-heptafluoropropyl-3-nitrobenzene, reduction of which by hydrogen in the presence of Raney nickel gives 3-heptafluoropropylaniline, which on reacting with 2-chlorobenzoic acid yields 2 - (3 - heptafluoropropylphenylamino) - benzoic acid, decarboxylation of which gives 3-heptafluoropropyldiphenylamine, which on reacting with sulphur in the presence of iodine yields 2-heptafluoropropylphenthiazine.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US658526A US3058979A (en) | 1957-05-13 | 1957-05-13 | New perfluoroalkylphenothiazine derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
GB829246A true GB829246A (en) | 1960-03-02 |
Family
ID=24641614
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB32856/57A Expired GB829246A (en) | 1957-05-13 | 1957-10-21 | Improvements in or relating to new perfluoroalkyl-phenothiazine derivatives |
Country Status (2)
Country | Link |
---|---|
US (1) | US3058979A (en) |
GB (1) | GB829246A (en) |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3194733A (en) * | 1961-04-26 | 1965-07-13 | Olin Mathicson Chemical Corp | Phenothiazine compositions and method of treating mental disorders |
US7544681B2 (en) * | 2001-09-27 | 2009-06-09 | Ramot At Tel Aviv University Ltd. | Conjugated psychotropic drugs and uses thereof |
US8207369B2 (en) | 2008-02-11 | 2012-06-26 | Ramot At Tel-Aviv University Ltd. | Conjugates for treating neurodegenerative diseases and disorders |
US8222296B2 (en) | 2006-07-17 | 2012-07-17 | Ramot At Tel-Aviv University Ltd. | Conjugates comprising a GABA- or glycine compound, pharmaceutical compositions and combinations thereof and their use in treating CNS disorders |
WO2013138101A2 (en) | 2012-03-16 | 2013-09-19 | Children's Medical Center Corporation | Calmodulin inhibitors for the treatment of ribosomal disorders and ribosomapathies |
US8916610B2 (en) | 2010-09-22 | 2014-12-23 | Ramot At Tel-Aviv University Ltd. | Acid addition salt of a nortriptyline-GABA conjugate and a process of preparing same |
US8975251B2 (en) | 2009-12-09 | 2015-03-10 | Bar-Ilan University | Methods of improving cognitive functions |
CN105153062A (en) * | 2015-10-10 | 2015-12-16 | 江苏宝众宝达药业有限公司 | Preparation method of permitil |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3394131A (en) * | 1961-04-26 | 1968-07-23 | Squibb & Sons Inc | Acid esters of phenothiazine |
US3152126A (en) * | 1963-01-14 | 1964-10-06 | Olin Mathieson | New diesters of phenothiazines |
US3282934A (en) * | 1964-05-15 | 1966-11-01 | Schering Corp | Nitrogenous esters of hydroxylalkylamino phenothiazines |
US3317537A (en) * | 1965-06-25 | 1967-05-02 | Colgate Palmolive Co | Piperazinoalkyl-morphanthridines |
US5223497A (en) * | 1989-03-31 | 1993-06-29 | Yale University | Treating habit disorders |
US5114942A (en) * | 1989-03-31 | 1992-05-19 | Yale University | Treating habit disorders |
US5059600A (en) * | 1989-03-31 | 1991-10-22 | Yale University | Treating habit disorders |
HU213271B (en) * | 1990-06-01 | 1997-04-28 | Merrell Dow Pharma | Process for producing (+)-alpha-(2,3-dimethoxi-phenyl)-1-[2-(4-fluoric-phenyl)-ethyl]-4-piperidine-methanole and pharmaceutical compositions containing the same |
US6004980A (en) * | 1990-06-01 | 1999-12-21 | Merrell Pharmaceuticals, Inc. | (+)-α-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol |
JP2001501629A (en) | 1996-10-04 | 2001-02-06 | ノボ ノルディスク アクティーゼルスカブ | N-substituted azaheterocyclic compounds |
US6028083A (en) * | 1997-07-25 | 2000-02-22 | Hoechst Marion Roussel, Inc. | Esters of (+)-α-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl) ethyl]-4-piperidinemethanol |
WO2003106660A2 (en) * | 2002-06-17 | 2003-12-24 | Philadelphia Health And Education Corporation | Immunomodulation and effect on cell processes relating to serotonin family receptors and the blood-brain barrier |
EP1470818B1 (en) * | 2003-04-25 | 2006-07-26 | Neuro3D | Use of piperazine phenothiazine derivatives in the manufacture of a medicament with neuroprotector and/or neurotrophic effects on cns and/or pns |
WO2006116221A2 (en) * | 2005-04-22 | 2006-11-02 | Wyeth | Therapeutic combinations for the treatment or prevention of psychotic disorders |
EP2061788A4 (en) * | 2006-09-01 | 2010-10-06 | Immune Control Inc | Novel compositions and methods for treatment of diseases related to activated lymphocytes |
GB0701970D0 (en) * | 2007-02-01 | 2007-03-14 | Wilson Stuart | Treatment of protein aggregation diseases |
EP3574920A1 (en) * | 2018-05-31 | 2019-12-04 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Nupr1 inhibition for treating cancer |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL89749C (en) * | 1954-04-27 | |||
NL108827C (en) * | 1956-04-09 | |||
BE558008A (en) * | 1956-06-21 |
-
1957
- 1957-05-13 US US658526A patent/US3058979A/en not_active Expired - Lifetime
- 1957-10-21 GB GB32856/57A patent/GB829246A/en not_active Expired
Cited By (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3194733A (en) * | 1961-04-26 | 1965-07-13 | Olin Mathicson Chemical Corp | Phenothiazine compositions and method of treating mental disorders |
US8283381B2 (en) | 2001-09-27 | 2012-10-09 | Ramot At Tel-Aviv University Ltd. | Conjugated psychotropic drugs and uses thereof |
US7544681B2 (en) * | 2001-09-27 | 2009-06-09 | Ramot At Tel Aviv University Ltd. | Conjugated psychotropic drugs and uses thereof |
US7619006B2 (en) * | 2001-09-27 | 2009-11-17 | Ramot At Tel Aviv University Ltd. | Conjugated psychotropic drugs and uses thereof |
US7939525B2 (en) | 2001-09-27 | 2011-05-10 | Bar-Ilan University | Conjugated psychotropic drugs and uses thereof |
US8168628B2 (en) | 2001-09-27 | 2012-05-01 | Ramot At Tel-Aviv University Ltd. | Conjugated psychotropic drugs and uses thereof |
US7598239B2 (en) * | 2001-09-27 | 2009-10-06 | Ramot At Tel Aviv University Ltd. | Conjugated psychotropic drugs and uses thereof |
US8222296B2 (en) | 2006-07-17 | 2012-07-17 | Ramot At Tel-Aviv University Ltd. | Conjugates comprising a GABA- or glycine compound, pharmaceutical compositions and combinations thereof and their use in treating CNS disorders |
US8377990B2 (en) | 2006-07-17 | 2013-02-19 | Ramot At Tel-Aviv University Ltd. | Conjugates comprising a psychotropic drug or a GABA agonist and an organic acid and their use in treating pain and other CNS disorders |
US8207369B2 (en) | 2008-02-11 | 2012-06-26 | Ramot At Tel-Aviv University Ltd. | Conjugates for treating neurodegenerative diseases and disorders |
US8722923B2 (en) | 2008-02-11 | 2014-05-13 | Ramot At Tel-Aviv University Ltd. | Conjugates for treating neurodegenerative diseases and disorders |
US8975251B2 (en) | 2009-12-09 | 2015-03-10 | Bar-Ilan University | Methods of improving cognitive functions |
US8916610B2 (en) | 2010-09-22 | 2014-12-23 | Ramot At Tel-Aviv University Ltd. | Acid addition salt of a nortriptyline-GABA conjugate and a process of preparing same |
WO2013138101A2 (en) | 2012-03-16 | 2013-09-19 | Children's Medical Center Corporation | Calmodulin inhibitors for the treatment of ribosomal disorders and ribosomapathies |
EP3461482A1 (en) | 2012-03-16 | 2019-04-03 | Children's Medical Center Corporation | Calcium channel blockers for the treatment of ribosomal disorders and ribosomapathies |
CN105153062A (en) * | 2015-10-10 | 2015-12-16 | 江苏宝众宝达药业有限公司 | Preparation method of permitil |
Also Published As
Publication number | Publication date |
---|---|
US3058979A (en) | 1962-10-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB829246A (en) | Improvements in or relating to new perfluoroalkyl-phenothiazine derivatives | |
US2750387A (en) | Basically substituted derivatives of diarylaminobenzamides | |
US3621043A (en) | N-substituted octadecadienoic acid amides as cholesterol lowering agents | |
ATE24904T1 (en) | COMPOUNDS EFFECTIVE IN TREATMENT OF STOMACH ULCERS AND SKIN SENSITIVITY SYMPTOMS. | |
US2908683A (en) | Phenthiazine derivatives | |
CH449632A (en) | Process for the preparation of cyclic diazacycloalkane compounds | |
US2862965A (en) | Pharmaceutical compounds | |
US3270004A (en) | Disubstituted piperazines useful as schistosomiasis agents | |
US2824102A (en) | Aminoalkyl-2h, 1, 4-benzothiazin-3(4h)-ones | |
US2847419A (en) | Propynyl dithiocarbamates | |
US3480663A (en) | Terpene ester carbamic acids | |
US2683735A (en) | Aromatic esters of basically substituted isocyclyl carbamates | |
US3541090A (en) | Production of substituted tetrahydro-1,4-thiazine-1,1-dioxides | |
US3223703A (en) | 3-carbalkoxy- and 3-carbamoyl-5-subtituted - (2h) - 1,2,6 - thiadiazine - 1,1-dioxides and process | |
DE2316765A1 (en) | PROCESS FOR THE PREPARATION OF 2CHINOXALINCARBOXAMIDE-1,4-DIOXIDES | |
US3544587A (en) | Substituted toluidides and compositions containing them | |
US3562267A (en) | Derivatives of 3-(5-nitrofur-2-yl)-5-aminoisoxazoles | |
US2772288A (en) | Basic esters of n-aryl and n-cycloalkyl indancarbamic acids, their salts and methods for their preparation | |
US3711538A (en) | Delta 2,alpha-adamantaneacetanilide derivatives and related compounds | |
US2578053A (en) | Piperazine oxides and method of | |
US3470173A (en) | 1-chloro-cycloalkane-1-carbox amides | |
GB889223A (en) | Phenylpiperazinylalkyl esters and amides | |
GB938646A (en) | New piperazine derivatives | |
US3590030A (en) | Sulfenamides of carbodithioic acid containing azabicyclononane | |
US3057933A (en) | Vulcanizing rubber with 1-thiazolyl unsymmetrical-1, 4-piperazines |